A Delaware jury ordered Illumina to pay more than $333 million to a U.S. unit of Chinese genetic analysis company after finding that the San Diego company’s DNA-sequencing systems infringed two patents.
A Delaware jury ordered Illumina to pay more than $333 million to a U.S. unit of Chinese genetic analysis company after finding that the San Diego company’s DNA-sequencing systems infringed two patents.
This website, like most media sites, uses small files called cookies to anonymously customize the advertising that you see. Learn more about how we use cookies in our cookie policy.
